chevron_leftBack
As of 9 June 2026, Kunming Longjin Pharmaceutical Co., Ltd. has a market cap of $34.87M USD, ranking #33165 globally and #6162 in China.
It ranks #2995 in the Healthcare sector, and #176 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$34.87MUSD
236.3M CNY
Enterprise Value
-$1.56MUSD
-10.56M CNY
Revenue (TTM)
$6.79MUSD
45.99M CNY
EBITDA (TTM)
-$5.63MUSD
-38.11M CNY
Net Income (TTM)
-$6.06MUSD
-41.03M CNY
EBITDA Margin
-83%
Profit Margin
-89%
PS Ratio
5.1
PB Ratio
0.5
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Lijuan Fan
open_in_new
Employees
188
Founded
1996
Website
longjin.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 3.5% | -3.3% | -49% | -62% | -75% | -65% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002750
昆明龙津药业股份有限公司 Class A
ISIN: CNE1000021X8
Shares Out.:
Shares Outstanding:
400.5M1
Shares Float:
241.417M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.5900 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Kunming Longjin Pharmaceutical Co., Ltd.
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business. Kunming Longjin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Kunming, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.84B
45K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.09B
26K%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.21B
15K%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.2B
12K%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.26B
9K%
22.12B CNY
|
8.1
|
|
|
$2.74B
8K%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.17B
106K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
85K%
|
-
|
|
NSE: CIPLA
|
$11.16B
32K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
32K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.72B
25K%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.46B
24K%
807.02B INR
|
23.1
|
chevron_leftBack